← Today’s ReceiptsSource pending
Public-record receiptR-FLSource pending
C. Franklin disclosed BUY $MRK
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$1K – $15K
Filed
2025-07-03
Trade date
2024-08-07
Disclosure lag
330 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 330 days after the trade date, beyond the standard 45-day STOCK Act window.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
48 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for C. Franklin, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Market context is shown as a post-trade reference (-34.2% versus SPY); it is not a trading recommendation.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-07-03 · disclosed 330d after transaction
Market context
Merck & Co. Inc.
Sector: Healthcare
Vs SPY: -34.2%
Factual flags
- Filed after the standard 45-day STOCK Act window.
- 8 nearby same-ticker disclosures in the surrounding 30-day window.
- Filed 330 days after the reported transaction date (standard disclosure window: 45 days).
- 3 members disclosed MRK within a 7-day span starting 2024-08-02.
Member trail
C. Franklin
U.S. House · FL-18
House Committee on ScienceSpaceand TechnologyHouse Committee on Appropriations
Ticker trail
$MRK
Merck & Co. Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.